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Cerebral palsy (CP) is the most common movement disorder in children. A diagnosis
of CP is often made based on abnormal muscle tone or posture, a delay in reaching
motor milestones, or the presence of gait abnormalities in young children. Neuroimaging
of high-risk neonates and of children diagnosed with CP have identified patterns of
neurologic injury associated with CP, however, the neural underpinnings of common gait
abnormalities remain largely uncharacterized. Here, we review the nature of the brain
injury in CP, as well as the neuromuscular deficits and subsequent gait abnormalities
common among children with CP. We first discuss brain injury in terms of mechanism,
pattern, and time of injury during the prenatal, perinatal, or postnatal period in preterm
and term-born children. Second, we outline neuromuscular deficits of CP with a
focus on spastic CP, characterized by muscle weakness, shortened muscle-tendon
unit, spasticity, and impaired selective motor control, on both a microscopic and
functional level. Third, we examine the influence of neuromuscular deficits on gait
abnormalities in CP, while considering emerging information on neural correlates of
gait abnormalities and the implications for strategic treatment. This review of the neural
basis of gait abnormalities in CP discusses what is known about links between the
location and extent of brain injury and the type and severity of CP, in relation to
the associated neuromuscular deficits, and subsequent gait abnormalities. Targeted
treatment opportunities are identified that may improve functional outcomes for children
with CP. By providing this context on the neural basis of gait abnormalities in CP, we
hope to highlight areas of further research that can reduce the long-term, debilitating
effects of CP.
Keywords: cerebral palsy, brain injury, neuroimaging, neuromuscular deficits, gait
Abbreviations: ADC, apparent diffusion coefficient; ATP, adenosine triphosphate; BGTL, basal ganglia and/or thalamus
lesions; BoNT-A, botulinum toxin-A; CP, cerebral palsy; CST, corticospinal tract; CT, computed tomography; DTI, diffusion
tensor imaging; EMG, electromyography; GM, gray matter; GMFCS, Gross Motor Function Classification Scale; MRI,
magnetic resonance imaging; MVC, maximal voluntary contraction; PVL, periventricular leukomalacia; SCALE, Selective
Control Assessment of the Lower Extremity; SMC, selective motor control; TD, typically developing; VLBW, very low
birthweight; WM, white matter.
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INTRODUCTION
Cerebral palsy is the most common movement disorder in
children, with an overall prevalence worldwide of 2–3 per 1,000
live births, and a much higher prevalence of 60–150 per 1,000
among neonatal survivors weighing less than 1500 grams at
birth (Oskoui et al., 2013). A diagnosis of CP is often made
based on the observation of abnormal muscle tone or posture,
delayed motor milestones, or the presence of gait abnormalities
in young children, which range from mild, i.e., toe-walking, to
severe, i.e., crouched, internally rotated gait (Wu et al., 2004).
Gait begins to stabilize around age 3–4 years and matures by
7 years of age (Wu et al., 2015). Among children with CP who
are not walking by age 2 years, only 10% walk independently
by age 7 (Wu et al., 2004), underscoring the importance
of early identification and intervention. In recent years, 3D
gait analysis has become the gold standard for delineating
gait abnormalities in children with CP (Gage and Novacheck,
2001). Furthermore, neuroimaging of high-risk neonates and of
children diagnosed with CP have identified patterns of neurologic
injury associated with CP. However, the link between neurologic
injury, neuromuscular deficits, and specific gait abnormalities in
CP is not well understood. This review of the neural basis of gait
abnormalities in CP discusses what is known about links between
the location and extent of brain injury and the type and severity
of CP, in relation to the associated neuromuscular deficits, and
subsequent gait abnormalities. We discuss current literature that
addresses the nature of the brain injury in CP, as well as the
neuromuscular deficits and subsequent gait abnormalities in CP
on both a microscopic and functional level. Ultimately, we hope
that this review clarifies some of the neurologic correlates of gait
abnormalities and points to areas of further research that can
improve functional outcomes for children with CP.
BRAIN INJURY IN CEREBRAL PALSY
Cerebral palsy describes “a group of permanent disorders
affecting the development of movement and posture, causing
activity limitation, that are attributed to non-progressive
disturbances that occurred in the developing fetal or infant
brain” (Rosenbaum et al., 2007). Although the initial brain
injury is non-progressive, the musculoskeletal impairments and
functional limitations associated with CP are indeed progressive
(Bell et al., 2002; Sanger, 2015). A loss of oxygen to the developing
brain, i.e., hypoxia-ischemia, is the primary mechanism by
which brain injury occurs in CP. Other causes of brain injury
include hemorrhage, infection, metabolic derangement, brain
malformation, and bilirubin neurotoxicity. In contrast, birth
asphyxia resulting in CP is relatively rare, accounting for
<10% cases, (Paneth et al., 2006; Strijbis et al., 2006; Ellenberg
and Nelson, 2013), and evidence of genetic influences on
development of CP is newly emerging and thought to contribute
to up to 30% of CP cases (Costeff, 2004; Moreno-De-Luca et al.,
2012; MacLennan et al., 2015). The prevalence of CP increases
with prematurity, ranging from 1.1 per 1000 infants born at
40 weeks’ gestation to 90.7 per 1000 infants born at 26 weeks’
gestation (Trønnes et al., 2014). The risk of CP decreases linearly
with increasing gestational age: 8.5% for 23–27 weeks, 5.6% for
28–30 weeks, 2.0% for 31–33 weeks, 0.4% for 34–36 weeks, and
0.2% for 37+ weeks gestation. Male sex is also a general risk
factor, as the rate of CP per 1000 male births exceeds that among
females by about 30% (Jarvis et al., 2005).
There are three main types of CP: spastic, dyskinetic,
and ataxic. Spastic CP is the most common, affecting
approximately 87% of children with CP, while dyskinetic CP
affects approximately 7.5%, and ataxic CP affects approximately
4% of children with CP (Sellier et al., 2016). There is evidence
that different types of CP each have primary regions of brain
damage linked to characteristic motor deficits, though different
types of CP can co-exist. Emerging research indicates that spastic
CP is associated with brain damage to cortical motor areas and
underlying WM, dystonic CP is associated with damage to basal
ganglia, and ataxic CP is associated with damage to cerebellar
structures (Figure 1). In general, periventricular WM lesions are
generally associated with mild and moderate motor impairments
of spastic CP with fewer accompanying impairments, whereas
brain maldevelopment and cortical/subcortical and basal ganglia
lesions are associated with more severe and a greater number
of accompanying impairments, such as cognitive and language
deficits (Himmelmann and Uvebrant, 2011).
Spastic CP is often linked to damage to the periventricular
WM due to hypoxia-ischemia, which may be caused by various
maternal or prenatal factors. Spastic CP is further delineated
by the distribution of affected limbs: hemiplegia, diplegia, and
tetraplegia (also referred to as quadriplegia). Individuals with
spastic CP present with varying degrees of weakness, short
muscle-tendon unit, spasticity, and impaired SMC. In spastic CP,
the severity of motor deficits, the distribution of affected limbs,
and the extent to which the motor deficits involve distal to more
proximal joints within a limb, are thought to be determined by
the severity and extent of the brain injury (Serdaroglu et al.,
2004), consistent with anatomical representation of the cortical
homunculus and descending fibers (Figure 1). More medial
brain injury, i.e., closer to the ventricles, results in more mild
involvement of distal joints. More extensive injury that extends
to lateral portion of periventricular WM results in more severe
involvement of both distal and proximal joints. Accordingly,
Staudt et al. (2000) found a strong correlation between the
extent of the lateral lesion in the posterior semi-coronal plane
on MRI and the lower limb motor impairment score (r = 0.805,
p = 0.001). In addition, upper limb involvement is generally
associated with a greater degree of lateral damage compared to
lower limb involvement. Staudt et al. (2003) found that upper
limb dysfunction was observed only in patients with a lateral
lesion extent of 23 mm or more, whereas lower limb dysfunction
was present with a lateral lesion extent of 20 mm.
Dyskinetic CP is the second most common type of CP,
affecting approximately 7.5% of children with CP (Sellier et al.,
2016). It is often linked to damage of the subcortical GM,
i.e., basal ganglia and thalamus, due to hypoxia-ischemia, as
well as hyperbilirubinemia and birth asphyxia (Himmelmann
and Uvebrant, 2011). The definition of dyskinetic CP has
evolved recently to include dystonic and choreoathetoid CP
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FIGURE 1 | Brain regions and WM motor tracts affected in spastic, dyskinetic, and ataxic CP. A portion of the motor homunculus is superimposed on the
cortex. Representations of the lateral ventricles, subcortical nuclei, cerebellum, brain stem, and rubrospinal and CSTs are outlined. The vermis of the cerebellum
(posterior to the brainstem) is represented by dotted lines. Regions where the reticulospinal and vestibulospinal tracts descend through each layer of the brainstem
and the spinal cord are shaded.
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(Aravamuthan and Waugh, 2016). As noted by Sanger (2006),
symptoms of dyskinetic CP include both hyperkinetic and
dystonic limb movements that impair function. Currently, it has
not been determined whether these movements are random and
variable or involve a small number of specific abnormal motor
patterns (Sanger, 2006). The severity of motor impairment in
dyskinetic CP has been found to be associated with lower volumes
of the basal ganglia and thalamus (Laporta-Hoyos et al., 2014).
In a study of 18 children with basal ganglia lesions and CP, 13
children had a diagnosis of dyskinetic CP, 12 had a diagnosis of
dyskinetic CP with severe fine motor impairment and a GMFCS
(Palisano et al., 2008) level of IV or V, representing severe CP
with reduced or absent independent mobility (Himmelmann and
Uvebrant, 2011).
Ataxic CP is the least common type of CP and is associated
with cerebellar vermis injury, cerebellar malformations, and or
genetic mutations; ataxic CP is characterized by impaired limb
coordination during voluntary movements, as well as balance,
stability, and speech impairments (Hughes and Newton, 1992;
Schnekenberg et al., 2015; Graham et al., 2016). Few studies have
examined the neurologic correlates of ataxic CP. Miller and Cala
(1989) examined CT scans of 29 patients with ataxic CP born
at term: 7 had simple ataxic CP and 10 had ataxic diplegia,
which involves simple ataxia in addition to pyramidal signs of
spastic diplegic CP. They identified brain abnormalities in only
18/29 children. Of the 7 children with simple ataxia, 5/7 had
cerebral abnormalities and 4/7 had changes in the posterior fossa
involving the vermis (Miller and Cala, 1989). Similarly, Bax et al.
(2006) found that children with ataxic CP had the highest rate of
normal MRI (8 out of 17), suggesting a need for further research
utilizing higher resolution neuroimaging in ataxic CP.
Although early brain injury is the primary cause of CP, a
recent study using exome sequencing reported that 14% of
CP cases had causative single-gene mutations and up to 31%
had clinically relevant copy number variations, suggesting a
greater role of genetics in the development of brain injury
and CP than previously recognized (MacLennan et al., 2015).
Genes encoding processes related to catabolism of lipoprotein
constituents, procoagulant factors, factors influencing central
nervous system injury response, neuronal function (genes
for potassium channels), cytoskeleton-interacting proteins, and
adaptor proteins involved in intracellular trafficking are targets
of further research as potential culprits of genetic causes for CP
(Fahey et al., 2016). For the purposes of this review, we will focus
primarily on the neurologic correlates of gait abnormalities in CP
and the implications for treatment.
Currently, brain imaging using MRI is the gold standard
for identifying neural injury in CP. Recently, Fiori et al.
(2015) developed an MRI score that correlated with severity
of CP. In a review of six studies, including 1065 MRI and
CT images in children diagnosed with CP, the most common
injuries were WM injury (19–45% of images), GM injury (14–
22%), focal vascular insults (10%), malformations (11%), and
miscellaneous abnormalities (4–23%) (Reid et al., 2014). WM
injury was most common among all CP subtypes, though
children with spastic diplegia had the highest rate of WM injury
overall.
However, brain injuries in CP are not always visible on MRI;
a review by Reid et al. (2014) revealed that abnormal MRI
only accounts for about 86% of CP cases, i.e., 14% of children
clinically diagnosed with CP show no signs of brain injury on
MRI, particularly in children with ataxic CP, as noted above (Bax
et al., 2006). These findings may be explained by the limitations
of current imaging methodologies, such as insufficient spatial
resolution, to reveal micro-lesions (Leonard et al., 2011; Benini
et al., 2013). In fact, recent studies show that DTI can better
predict motor function deficits from WM damage in the posterior
limbs of the internal capsule than conventional MRI (Rose et al.,
2007; Benini et al., 2013). Furthermore, a recent publication
suggests that the combination of different MRI scans, including
volumetric imaging and DTI, can help to identify potential
relations between brain lesions and lower limb deficits or gait
pathology in children with spastic CP (Meyns et al., 2016b).
Selective vulnerability of developing WM to injury during
early phases of vascularization and WM myelination has been
widely recognized (Inder and Volpe, 2000; Hoon et al., 2009).
Regional differences in the trajectory of early WM development
(Dubois et al., 2014; Rose et al., 2014) can influence vulnerability
and thus the pattern of brain injury typically seen during the
preterm, term, or postnatal periods (Volpe, 2003; Graham et al.,
2016). That said, determining the time of onset of brain injury
in CP can be difficult to pinpoint. Here, we discuss brain
injury among infants based on a preterm (<37 weeks gestation)
versus term birth and specify the time of injury when reported
(Table 1).
Brain Injury in Preterm Infants
Incidence and Risk Factors in Preterm Infants
Preterm birth is associated with approximately one-third of all CP
cases (Oskoui et al., 2013) and approximately 30% of dyskinetic
CP (Himmelmann et al., 2009). Brain injury among preterm
TABLE 1 | Mechanisms and patterns of brain injuries commonly identified
in pre-term and term infants that contribute to CP.
Preterm infants Term infants
Mechanisms Mechanisms
Intraventricular hemorrhage Hypoxia-ischemia
Hypoxia-ischemia Inflammation
Inflammation Infection
Infection
Postnatal sepsis Postnatal sepsis
Postnatal brain injury Postnatal brain injury
Postnatal bilirubin toxicity
Patterns of injury Patterns of injury
Periventricular white mater lesions Border zone (watershed) white matter
Cystic periventricular leukomalacia injury
Non-cystic periventricular leukomalacia Combination deep gray matter and
Injury to thalamocortical sensory fibers white matter injury
Cortical and deep gray matter lesions Cystic encephalomalacia
Reduction in brain volumes Focal infarcts
Cerebellar injury Cerebellar injury
Brain malformations Brain malformations
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infants can occur in the prenatal, perinatal, or postnatal period.
The timing of the injury and the developmental stage of the brain
influences the type of deficit. For example, damage to the brain
during the late second trimester, in which the vulnerable process
of regional WM myelination of motor tracts occurs, results in
lasting motor dysfunction. Preterm birth in instances of PVL was
found by Serdaroglu et al. (2004) to correlate significantly with
spasticity.
Preterm infants have an increased risk of prenatal hypoxia-
ischemia, prenatal and postnatal intraventricular hemorrhage,
and PVL, and thus, an increased risk for CP. Complications
experienced by preterm infants such as sepsis and necrotizing
enterocolitis also increase the risk of CP (Mallard et al., 2013).
Indeed, VLBW preterm infants (≤1500 g at birth, ≤32 weeks)
who suffer relatively low levels of neonatal inflammation (based
on serum levels of C-reactive protein) during the first 2 weeks of
life, have a higher risk of neurodevelopmental impairment at 18–
22 months (Rose et al., 2016), and neonatal infection has been
shown to increase VLBW infants’ risk for WM abnormalities
that lead to neurodevelopmental impairment (Rose et al., 2014;
Rand et al., 2016). Prenatal brain lesions or cerebral infarction
can arise from thrombosis due to inflammation and low blood
flow in the placenta, brain, or other organs (Nelson and Blair,
2015).
Pregnancy complications are common in preterm birth (42%
of cases, n = 92,320) and often contribute to a diagnosis of CP.
Such complications include chorioamnionitis (11.2% absolute
risk of CP), cervical conization (9.3%), placental abruption
(8.7%), placenta previa (8.3%), congenital malformation (8.3%),
prolonged rupture of membranes (7.5%), intrauterine growth
restriction (7.1%), unspecified bleeding (6.8%), multiple births
(5.7%), and pre-eclampsia (3.7%) (Trønnes et al., 2014). Further,
maternal infections during pregnancy (excluding the common
cold, coughs, etc.) have been reported in 29.6% (118 of 400)
of cases of CP (Bax et al., 2006). Specifically, 19.2% of the
mothers reported a urinary tract infection during pregnancy and
15.5% of women reported taking antibiotics during pregnancy.
Twins have a greater risk of CP compared with singletons,
especially if the pair have growth discordance (Scher et al.,
2002). In addition, the in utero death of one twin leaves the
surviving infant at a tenfold increased risk for CP, as dispersed
intravascular coagulation and emboli in the vascular anastomoses
of the twin placenta likely contribute to prenatal cerebral injury
in the surviving twin (Scher et al., 2002; Nelson and Blair,
2015). Marked fetal growth restriction with presence of major
birth defects is also associated with an increased risk of CP
(Decouflé et al., 2001; Blair and Nelson, 2015). In addition,
sex differences in neurodevelopment have been identified: the
incidence of moderate-to-severe CP was found by Hintz et al.
(2015) to be 50% higher in males (10.7%) than in females
(7.3%) in extremely low-birthweight (<1000 g) preterm infants.
They found no measurable risk factors or events, including
a diagnosis of intraventricular hemorrhage on ultrasound,
that explained the sex differences in neurodevelopmental
outcomes. Findings indicate a distinct disadvantage in male
infants for developing CP that is exacerbated in the preterm
population.
Mechanisms of Injury in Preterm Infants
The regions of the brain adjacent to the lateral ventricles
are especially susceptible to hypoxia-ischemia, i.e., insufficient
blood flow combined with reduced concentration of oxygen
in arterial blood, during prenatal development. In the preterm
brain, the intrinsic architecture of the arterial border culminates
in end zones that lie within the WM. This physiologic
propensity to develop ischemia is further perturbed by impaired
regulation of cerebral blood flow and metabolic needs during
development (Khwaja and Volpe, 2008). Oligodendrocytes in the
periventricular WM actively proliferate and myelinate during the
third trimester (27–40 weeks gestation), and their high metabolic
demand renders them vulnerable in preterm infants (Raybaud,
1983; Talos et al., 2006).
The increased risk for infection/inflammation (including
ischemia-induced inflammation) during fetal development also
contributes to the mechanism of injury in PVL. Upregulation
of pro-inflammatory cytokines and activation of microglia
within immature WM results in damage to the vulnerable
premyelinating oligodendrocytes. This cell-specific damage
results in WM hypo-myelination, and necrotic microscopic
lesions lead to proliferation of glial cells in response to injury,
a common finding in non-cystic PVL and among preterm
children with CP (Graham et al., 2016). Mallard et al. (2013)
suggested that the inflammation-induced opening of connexin
hemichannels plays a pivotal role in initiating a cycle of excessive
ATP release, over-activation of purinergic receptors on microglia
and astrocytes, and subsequent brain damage.
After initial injury by hypoxia-ischemia and infection/
inflammation, excitotoxicity and free radical attack by
reactive oxygen and nitrogen species are the main downstream
mechanisms of injury in PVL. Current evidence supports that
oligodendroglial development is susceptible to oxidative attack
within a maturation-dependent window of vulnerability.
This window of vulnerability is due mainly to delayed
development of antioxidant enzymes and the acquisition of
iron for oligodendrocyte differentiation. Human brain studies
have shown a delay in the development of superoxide dismutase
(antioxidant) enzymes, e.g., manganese superoxide dismutase,
copper/zinc superoxide dismutase, and catalase (Folkerth et al.,
2004). Further, observations show that developing WM uses
iron both for oligodendrocyte differentiation (Connor and
Menzies, 1996) and to convert hydrogen peroxide to its hydroxyl
radical, thereby resulting in the increased free iron levels in the
cerebrospinal fluid of children with posthemorrhagic ventricular
dilation (Savman et al., 2001). Excitotoxicity likely leads to
injury to premyelinating oligodendrocytes by promoting Ca2+
influx and generation of reactive oxygen and nitrogen species.
Glutamate is capable of inducing maturation-dependent death
of premyelinating oligodendrocytes by receptor-mediated
mechanisms in vivo (Khwaja and Volpe, 2008). Premyelinating
oligodendrocytes contain glutamate receptors that, when
excessively activated, lead to cell injury. The excess glutamate
comes from oligodendrocytes that express AMPA/kainate-type
glutamate receptors and NMDA receptors, the over-activation of
which results in cell death (Káradóttir and Attwell, 2007; Khwaja
and Volpe, 2008). In addition, the AMPA/ kainate receptors have
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been found to be upregulated in premyelinating oligodendrocytes
rather than in mature oligodendrocytes (Rosenberg et al., 2003;
Jensen, 2005).
Patterns of Injury in Preterm Infants
Patterns of brain injury on MRI among preterm children with CP
who suffered hypoxia-ischemia revealed 51/104 (49%) had signs
of PVL or signal abnormalities in the periventricular WM (Sie
et al., 2000). Indeed, periventricular WM lesions are the most
common injury among preterm children, followed by cortical
and deep GM lesions (Hoon et al., 2009). Figure 2 highlights the
brain regions and WM tracts commonly affected in CP.
The WM tracts essential for motor function descend near
the periventricular region through the posterior limbs of the
internal capsule; therefore, periventricular WM injury may result
in impaired motor function and a diagnosis of CP (Figure 2).
The CST is the major WM tract responsible for voluntary
movement. About 40% of its fibers originate from the primary
motor cortex in the precentral gyrus; the other 60% originate in
the supplementary motor area, the premotor cortex, the somatic
sensory cortex, the parietal lobe, and the cingulate gyrus. These
fibers descend through the corona radiata and posterior limb
of the internal capsule to reach the brainstem, where 80% of
the fibers decussate at the spinomedullary junction and continue
FIGURE 2 | Diffusion-weighted image of an infant, highlighting brain
regions of interest commonly affected in CP, using the semi-
automated JHU neonatal atlas (http://cmrm.med.jhmi.edu/cmrm/
Data_neonate_atlas/atlas_neonate.htm). Axial view (A) and sagittal view
(B) of the genu (light-green) and splenium (dark-green) of the corpus
callosum, and anterior (red) and posterior (blue) limbs of the internal capsule.
An axial view (C) and coronal view (D) highlight the thalamus (green) and
globus pallidus (cyan). A, anterior; P, posterior; R, right; L, left. Figure reprinted
with permission from Rose et al. (2015) Pediatric Research.
http://www.nature.com/pr/journal/v78/n6/fig_tab/pr2015157f2.html
their descent contralaterally as the lateral CST (Mtui et al., 2016,
p. 169–178). Damage to developing WM in the CST is considered
a major mechanism for motor dysfunction in preterm children
with spastic CP (Roelants-van Rijn et al., 2001; Rose et al., 2007).
A growing body of evidence from DTI and tractography
studies suggests that thalamocortical sensory fibers are also
particularly vulnerable during the preterm period. The
thalamocortical sensory fibers extend from the thalamus to
the primary and secondary somatosensory areas, terminating
in cortical layers of the lateral postcentral gyrus. Injury to these
WM fibers can impair motor and somatosensory function in
children with CP (Hoon et al., 2002, 2009; Rose et al., 2011; Tsao
et al., 2015). Hoon et al. (2002, 2009) found that the severity of
injury in the thalamocortical sensory pathways correlated to the
severity of deficits in sensorimotor function in children with
CP born preterm. Similarly, abnormalities assessed using DTI
in preterm infants were seen in both CST and thalamocortical
projections to the somatosensory cortex, and both tracts were
associated with underlying pathology on conventional MRI
(Lennartsson et al., 2015).
Cortical GM and BGTL may occur in preterm children as a
result of hypoxia-ischemia. Injury to the GM has been linked
most frequently to spastic quadriplegic CP and dyskinetic CP
(Reid et al., 2014).
Preterm children may also have long-term reductions in
regional brain volumes of the sensorimotor cortex, which are
associated with poorer cognitive and visuomotor outcomes
(Peterson et al., 2000).
Postnatal Brain Injury in Preterm Infants
Preterm children may be more susceptible to brain injury or
insult during the postnatal period. Postnatal sepsis has been
associated with non-cystic PVL in preterm children who later
develop CP (Volpe, 2008). Male infants under 1 year of age, who
were born weighing less than 1500 g, are at the greatest risk
for developing CP following postnatal sepsis (Blair and Stanley,
1982). Other causes of postnatal brain injury resulting in CP
include cerebrovascular accidents, head trauma, and epilepsy
(Arens and Molteno, 1989; Australian Cerebral Palsy Register
Report [ACP], 2013). Postnatal intraventricular hemorrhage
among preterm children with CP can also result in cerebellar
injury, which may contribute to diminished walking and verbal
abilities, a higher incidence of epilepsy, and visual impairment
(Kitai et al., 2015). Postnatal bilirubin toxicity is a complication
among preterm infants that may be related to GM injury. The
exposure to even moderate levels of unconjugated bilirubin
may cause damage to the developing central nervous system,
specifically the basal ganglia and cerebellum. Brain lesions
identified on MRI following extreme hyperbilirubinemia have
been linked to dyskinetic CP, though this is rare in developed
countries (Rose et al., 2014) as a result of effective monitoring
and treatment for hyperbilirubinemia in preterm infants.
Brain Injury in Term-Born Infants
Incidence and Risk Factors in Term-Born Infants
The majority of CP cases (60%) are acquired in the term-born
population during the perinatal period (Australian Cerebral Palsy
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Register Report [ACP], 2013). Approximately 70% of dyskinetic
CP cases are linked to insults acquired in the term-born infant
(Himmelmann et al., 2009). The risk factors for CP among
term-born infants in developed countries include: placental
abnormalities, birth defects, low birthweight for gestational
age, meconium aspiration, instrumental/emergency Cesarean
delivery, neonatal seizures, respiratory distress syndrome,
hypoglycemia, and neonatal infection (Review: McIntyre et al.,
2013). Neonatal infections include chorioamnionitis (which has
been associated with WM damage), neurotropic virus infection,
cytomegalovirus infection, and maternal urinary tract infection
(Ahlin et al., 2013). Infection-related factors have been shown to
be independent risk factors for spastic hemiplegic CP, but not for
spastic diplegia, tetraplegia, or dyskinetic CP in term-born infants
(Ahlin et al., 2013). A recent review of 23 studies on perinatal
risk factors of CP refutes birth asphyxia as a primary cause of CP
(Ellenberg and Nelson, 2013).
Although perinatal ischemic stroke accounts for less than 5%
of all term-born CP cases (Wu et al., 2011), it accounts for 30%
of hemiplegic CP cases (Wu et al., 2006). Embolization from
the placenta near the time of delivery, a period characterized
by hypercoagulability, has been suggested as a cause of perinatal
stroke. Larger vessels are more frequently involved, especially the
left middle cerebral artery (Nelson and Blair, 2015) resulting in
left-sided brain lesions, which correspond to right-sided motor
deficits.
Mechanisms of Injury in Term-Born Infants
Neonatal encephalopathy due to presumed hypoxia-ischemia
remains an important clinical problem in term-born infants,
with placental pathology providing insight to the underlying
mechanisms. Among term-born infants, an elevated nucleated
red blood cell count in the placenta was significantly related to
watershed (border zone) WM brain injury (Frank et al., 2016).
A watershed (border zone) injury arises from prolonged, partial
ischemia of the WM between two major arteries, commonly the
anterior–middle and posterior–middle cerebral arteries. Further,
infants with small infarcts or an elevated nucleated red blood cell
count on placental pathology were less likely to develop BGTL
injury following perinatal hypoxia-ischemia, and were more
likely to have a favorable neurodevelopmental outcome. Frank
et al. (2016) have posited that both small infarcts and elevated
nucleated red blood cell counts, which reflect adverse intrauterine
conditions, might be involved in a pathway to preconditioning
resistance against acute brain injury, i.e., neuroprotective factors.
The mechanisms linking infection and cerebral ischemia are
still largely undetermined, but inflammation is thought to
exacerbate the natural prothrombotic state present during
normal pregnancy, and stimulates coagulation (Grau et al., 1995;
Ahlin et al., 2013).
Patterns of Injury in Term-Born Infants
In a study of 173 term-born infants with neonatal
encephalopathy, the pattern of brain injury on MRI revealed
45% of newborns had predominantly a watershed (border zone)
pattern of WM injury, 25% had BGTL injury and 30% had
normal MRI (Miller et al., 2005). The predominant region of
injury was often accompanied by lesser damage to other regions.
For example, 31% of newborns with the watershed (border
zone) predominant pattern had some BGTL injury, and 45%
of newborns with the BGTL predominant pattern had total
brain injury. The BGTL predominant pattern was significantly
associated with severe neonatal signs, encephalopathy, seizures,
and severe motor and cognitive outcome at 30 months.
Among term-born children with CP, Sie et al. (2000) found
that nearly 20% had bilateral BGTL injury involving the
putamen and thalamus. Among these children, one-third had
additional globus pallidus lesions and about half had additional
hippocampal lesions and WM abnormalities. These WM
abnormalities were unique from that of PVL and varied from
ventricular dilatation to diffuse and patchy mild WM signal
changes. Brain malformations, such as congenital microcephaly,
and GM lesions are more often seen in term-born children than
preterm children with CP (Miller et al., 2005; Krägeloh-Mann
and Horber, 2007).
Another pattern of injury present among term-born
children with CP and hypoxic-ischemic injury is multicystic
encephalopathy, which involves multiple large cystic cavities
in the WM separated from each other by membranes and is
associated with periventricular, subcortical, and cortical damage
(Sie et al., 2000).
Focal vascular insults are seen predominantly in term-born
children with hemiplegic CP, whereas malformations tend to be
associated with ataxic, quadriplegic, and diplegic CP (Reid et al.,
2014). Of these malformations, schizencephaly occurs more often
in patients with spastic hemiplegia than in any other CP subtype
(Kulak et al., 2011).
Postnatal Brain Injury in Term-Born Infants
Among 3135 individuals with CP born from 1993–2006, 5.6%
of individuals acquired a brain injury due to a recognized
event more than 28 days after birth, with the predominant
cause listed as cerebrovascular accident (34.2%) (Australian
Cerebral Palsy Register Report [ACP], 2013). The cerebrovascular
accident was either spontaneous, associated with surgery, or due
to complications of cardiac defects. Other causes of postnatal
brain injury in term-born infants leading to CP include head
trauma, cerebral infections, prolonged seizures, and respiratory
arrest or anoxia (Blair and Stanley, 1982; Arens and Molteno,
1989). Approximately 7% of dyskinetic CP cases are linked to
brain injuries incurred during the postnatal period (Kyllerman,
1982).
NEUROMUSCULAR DEFICITS OF
CEREBRAL PALSY
Neuromuscular deficits differ among spastic, dyskinetic, and
ataxic CP and involve abnormal motor drive, muscle tone, motor
patterns, and coordination caused by the original brain injury. In
addition, subsequent sensorimotor and musculoskeletal changes
result from chronic abnormal muscle activation, biomechanical
imbalance around joints, neglect, and/or disuse. These factors,
combined with rapid limb growth and increasing body weight
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in children, contribute to gait abnormalities in CP (Meyns et al.,
2016a).
Neuromuscular Deficits of Spastic CP
In spastic CP, neurological injury to the CST results in four
interrelated neuromuscular deficits: muscle weakness, shortened
muscle-tendon unit, spastic and passive resistance to stretch,
and impaired SMC. These deficits arise from brain injury and
subsequent changes in the motor unit, muscle growth, and
muscle fiber composition. Further involvement of sensory-motor
regions can impair proprioception and motor function (Hoon
et al., 2009). Together, these neuromuscular deficits result in the
gait abnormalities commonly seen in children with spastic CP.
The motor unit is the functional unit of the motor system,
consisting of a single motor neuron, the neuromuscular junction,
and the muscle fibers innervated by the motor neuron. In
the gastrocnemius, for example, a motor unit consists of
a single motor neuron with approximately 2000 associated
muscle fibers, whereas smaller muscles in the hand that are
responsible for fine motor control have a much smaller muscle
fiber-to-motor neuron ratio. Rose and McGill (2005) found
reduced neuromuscular activation and motor-unit firing rates
in the medial gastrocnemius and tibialis anterior in spastic CP.
The altered neural input to muscle has been associated with
altered muscle growth, fiber type and size variability, sarcomere
length, as well as altered collagen, fat, and extracellular matrix
composition. These changes in skeletal muscle morphology
contribute to functional changes in muscle strength, the length of
the muscle-tendon unit, and the reflexive and passive resistance
to stretch.
Muscle fiber development and growth rely on a number of
neuronal, nutritional, and hormonal factors, as well as initial
and repeating patterns of muscle use (Kimball and Jefferson,
2010; Braun and Gautel, 2011; Gundersen, 2011). Muscle growth
increases rapidly during the prenatal and neonatal periods. For
example, the sartorius muscle fibers double in diameter between
mid-gestation and term (Moore et al., 1971), and accelerated
growth in overall muscle fiber diameter has been noted between
35 weeks of gestation and term (Schloon et al., 1979). Thus,
preterm delivery may interfere with early muscle growth, and
compromised nutritional status in the preterm infant likely
contributes to poor skeletal muscle growth (Thorn et al., 2009).
It has been shown that muscle size is reduced in spastic CP
(Barber et al., 2011), and muscle volume is especially reduced in
the gastrocnemius and semitendinosus, both of which are critical
for gait (Smith et al., 2011). Recent work by Dayanidhi and
Lieber (2014) suggests that satellite cells also play an important
role in muscle growth. Muscle biopsies from children with
CP had 60–70% fewer satellite cells when compared to that
of age-matched, TD children, which may contribute to muscle
contracture in CP.
Muscle biopsy reveals an increased proportion of type-1
muscle fibers and an increased variability in muscle fiber diameter
in the muscles affected by spastic CP, likely as a result of
prolonged low-frequency motor unit firing rates (Rose et al.,
1994). Complex changes occur at both the level of the fiber and
the gross muscle, including an altered transcriptional profile,
increased sarcomere length, stiffer extracellular matrix, and
reduced overall muscle length, all of which contribute to muscle
contracture (Smith et al., 2011). Other changes in spastic muscle
in CP include increased collagen (Booth et al., 2001) and fat
content (Johnson et al., 2009). Although spastic muscle contains
a larger amount of extracellular matrix material compared with
normal muscle, the quality of the extracellular matrix is much
lower, contributing to the overall increased stiffness (Lieber et al.,
2003).
Weakness in Spastic CP
Children with spastic CP suffer from significant weakness that
contributes to abnormal posture and movement (Brown et al.,
1991; Damiano et al., 1995; Rose and McGill, 2005; Barber et al.,
2012; Noble et al., 2014). Studies suggest that the loss of excitatory
motor signals descending in the CST results in reduced muscle
activation and reduced muscle size, which is aggravated further
by pathological changes in the elasticity of the muscle (Brown
et al., 1991; Wiley and Damiano, 1998; Engsberg et al., 2000).
MVC of the quadriceps, plantar flexors, and dorsiflexors are
significantly reduced in CP (Damiano et al., 2002; Elder et al.,
2003; Rose and McGill, 2005; Stackhouse et al., 2005; Barber et al.,
2012). Barber et al. (2012) found a 33% lower ankle plantarflexion
torque in children with spastic CP compared to their TD peers.
This reduced ankle plantarflexion torque was partially explained
by 37% smaller medial gastrocnemius muscle and 4% greater
antagonistic co-contraction.
It has been posited that individuals with spastic CP do
not develop sufficient tension frequently enough to encourage
normal muscular growth (Noble et al., 2014). Noble et al. (2014)
found that the medial and lateral gastrocnemius, soleus, tibialis
anterior, rectus femoris, semimembranosus, and semitendinosus
of patients with CP had reduced volumes compared to TD
children, even when adjusted for body mass. This lack of growth
may be mediated through reduced muscle and neurotrophic
factors that are released in response to neuronal activation,
acetylcholine release, and contraction (Gough and Shortland,
2012), further contributing to weakness. Affected muscles in
spastic CP have substantially reduced neuromuscular activation
and strength (Damiano et al., 2001; Rose and McGill, 2005;
Stackhouse et al., 2005) and an inability to sufficiently recruit and
drive motor-units at higher firing rates (Rose and McGill, 2005).
Further, musculoskeletal manifestations progress as skeletal
growth out-paces muscle growth, leading to reduced muscle
volumes associated with weakness (Noble et al., 2014). Muscle
endurance is also reduced in CP compared to TD individuals;
specifically, adolescents with CP have a reduced capacity to
endure activities at similar relative loads compared with TD
adolescents (Eken et al., 2014).
Common surgical procedures for CP negatively affect muscle
strength. For example, selective dorsal rhizotomy reduces
antigravity support that may have been provided by spasticity
(Giuliani, 1991), surgical muscle-lengthening or tendon transfer
decrease muscle force production, intrathecal baclofen directly
weakens the muscle to reduce spasticity (Hallett, 2000), and
orthoses or serial casting may exacerbate weakness due to
immobilization. Similarly, BoNT-A weakens the injected muscles
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in order to reduce spasticity (Hallett, 2000). However, a more
recent study on the effects of BoNT-A suggests no decrease
in long-term muscle strength at 6 weeks or 6 months after a
one-time injection of BoNT-A in children with CP (Eek and
Himmelmann, 2016).
While the neural correlates of muscle weakness are not
well studied, Meyns et al. (2016b) recently found a correlation
between asymmetry in strength and asymmetry in the CST ADC
calculated from DTI (r = 0.639, p < 0.034) of the segment of
the CST that runs through the posterior limb of the internal
capsule (CSTPLIC). Thus, greater asymmetry in strength was
associated with a greater ADC asymmetry of the CSTPLIC.
Further research is needed to clarify the brain structure-function
relations underlying weakness in spastic CP to develop effective
treatments.
Short Muscle-Tendon Unit in Spastic CP
Impaired muscle growth and muscle fiber changes result in a
shortened muscle-tendon unit in the muscles affected by spastic
CP. The failure of muscle growth to keep pace with bone
growth is most evident in the bi-articular muscles, e.g., the
gastrocnemius, hamstrings, and rectus femoris, and contributes
to joint contractures and gait abnormalities such as toe-walking
and flexed-knee gait.
Among TD children ages 5–12 years, the medial gastro-
cnemius has been shown to demonstrate 20% longitudinal
growth compared to 80% cross-sectional growth of muscle fibers
(Benard et al., 2011). In the CP population, while muscles
on the affected side of children with hemiplegic CP were
smaller compared to the unaffected side, the altered morphology
was not due to a decrease in fascicle length, i.e., longitudinal
growth, but rather a lack of cross-sectional growth (Barrett and
Lichtwark, 2010). Similarly, Shortland et al. (2001) concluded
that a smaller medial gastrocnemius in ambulatory children with
spastic diplegia was not due to reduced muscle fiber length,
but rather to shortened aponeuroses of the pennate muscle
via reduced muscle fiber cross-sectional diameter. Shortened
muscle tendon units in spastic CP result in part from reduced
muscle growth. Barber et al. (2016) found that normalized
medial gastrocnemius muscle growth rate was significantly less
in children with unilateral CP compared to children with bilateral
CP and TD children. Treatment with muscle growth factors has
not been studied to date, however, it has potential to increase
muscle size and length and warrants investigation as a treatment
for CP. Smith et al. (2009) assessed the transcriptional profile in
biopsies of spastic muscle in six children with CP and compared
it with that of two typically developing children. They noted
competing upregulation of both insulin-like growth factor 1
and myostatin, as well as an aberrant regulation of excitation-
contraction coupling genes. More research is needed to better
characterize the adaptations occurring at a molecular level, but
these studies point to growth factors as an avenue of research for
novel therapies.
The short muscle-tendon unit also likely contributes to
weakness. The active force generated by muscle is a function
of the number of cross-bridges formed, which depends on
the extent of myofilamentary overlap. Muscle force is maximal
at intermediate muscle lengths with optimal myofilament
overlap and declines at shorter and longer relative lengths
(Gordon et al., 1966). Thus, short muscles with lengthened
sarcomeres, as has been found in spastic muscle in CP (Lieber
et al., 2004), may result in an inefficient overlap of myofilaments,
thereby contributing to weakness. Research on the neural
correlates of short muscle-tendon unit is needed, considering
the impact of reduced descending excitatory signals on muscle
growth, muscle-to-bone growth rate discrepancy, and muscle
fiber diameter.
Spasticity in Spastic CP
Resistance to muscle stretch in children with spastic CP is
primarily due to two factors: neural-mediated reflex stiffness
(muscle spasticity) and passive muscle stiffness. Spasticity and
passive resistance to muscle stretch particularly influence bi-
articular muscles, such as the rectus femoris, hamstrings, and
gastrocnemius, which require greater excursion across two joints.
Spasticity has been defined as “a velocity-dependent increase
in muscle tone with exaggerated tendon jerks, resulting from
hyper-excitability of the stretch reflex” (Mayer, 1997). Loss of
descending inhibition of the stretch reflex pathway to affected
muscles in spastic CP may result in increased sensitivity to stretch
(Rose and McGill, 1998).
In addition to the velocity-dependent sensitivity to stretch
(Sanger et al., 2003), spasticity may also be position-dependent.
Wu et al. (2010) found that evaluating patients at different
velocities and positions helped to distinguish passive stiffness
from spasticity. The delayed catch angle at higher velocities may
be due to position change, as the joint is moved into a stiffer
position.
Although muscle spasticity is a primary symptom of spastic
CP, objective quantification has been challenging (Bar-On
et al., 2014b). Recent data on the profile of imposed muscle
accelerations, including the muscle length–velocity relationship,
hold promise for quantifying spasticity. Bar-On et al. (2014c)
quantified integrated biomechanical (joint position and torque)
and electrophysiological (surface EMG) signals of manually
performed passive stretches on the medial hamstrings and
gastrocnemius and found that measurement reliability was
moderately high for both muscles, and spasticity parameters
were significantly higher in children with spastic CP than in
TD children. Similarly, biomechanical parameters quantifying
the neural and non-neural contributions to ankle joint torque
were measured during manually applied passive stretches
to the gastroc-soleus in children with spastic CP, and the
parameters based on modeling of passive muscle stiffness
and viscosity were able to detect a significant decrease in
spasticity (p = 0.012) following BoNT-A in 53 children with
spastic CP (Bar-On et al., 2014a). This type of musculoskeletal
modeling combined with spasticity measurement may allow for
individually tailored spasticity treatments. Further, investigation
of fast and slow passive rotations imposed during manual
and motorized assessments may yield greater insights into the
development of movement profiles to better mimic spasticity
imposed during functional tasks such as walking (Sloot et al.,
2016).
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Increased passive muscle stiffness has been demonstrated
in spastic CP. Lee et al. (2016) used shear wave elastography
to measure muscle stiffness in eight children with hemiplegic
CP and found that the more-affected limb had greater muscle
stiffness than the less-affected limb. The increased passive
mechanical stiffness accounted for nearly all of the measurable
increase in joint stiffness (Lieber et al., 2004), suggesting that
spastic muscles have an altered resting sarcomere length and
altered cellular elastic modulus. Smith et al. (2011) also found
that the increased stiffness of hamstring contractures in children
with spastic CP compared to age-matched, TD children was likely
due to increased stiffness of the extracellular matrix and increased
in vivo sarcomere length.
Neural correlates of spasticity are emerging. Serdaroglu et al.
(2004) found PVL to be associated with spasticity. Specifically,
spasticity was found in 54 of 69 participants with body PVL and
in 7 of 20 without body PVL. Body PVL was defined as PVL
injury in the WM adjacent to the middle region of the lateral
ventricle. In addition, lower volume of the total corpus callosum
as well as lower volume in the posterior aspect of the central
corpus callosum correlated to increased incidence of spasticity
(Serdaroglu et al., 2004). Meyns et al. (2016b) recently found a
correlation between asymmetry in spasticity and asymmetry in
the CST ADC calculated from DTI (r= 0.608, p< 0.048). Further
study will clarify neural correlates and the mechanism underlying
spastic and passive resistance in muscle stretch and guide more
effective treatment.
Impaired Selective Motor Control in Spastic CP
Impaired SMC is defined as an “impaired ability to isolate
the activation of muscles in a selected pattern in response
to demands of a voluntary posture or movement” (Sanger
et al., 2006). Impaired SMC occurs when flexor or extensor
synergies interfere with isolated joint movements, resulting in
impaired functional movements, such as gait (Rose, 2009; Cahill-
Rowley and Rose, 2014). Children with mild to severe spastic
CP consistently demonstrate co-activation of the quadriceps
and gastrocnemius on EMG, distinguishing spastic CP from
idiopathic toe walking (Rose et al., 1999; Policy et al.,
2001). Individuals with CP demonstrate reduced complexity of
neuromuscular control during gait compared with unimpaired
individuals, as determined by the calculation of the muscle
synergies during gait (Steele et al., 2015).
Recent studies suggest that spared “extrapyramidal” motor
tracts, such as the rubrospinal and reticulospinal tracts, may
provide imperfect compensation in recovering motor function.
The rubrospinal tract originates in the red nucleus, crosses to the
other side of the midbrain, and enters the spinal cord adjacent
to the lateral CST. It is thought to mediate flexion and extension
movements (Mtui et al., 2016, p. 324–337) and is more developed
in infants than TD children and adults. However, rubrospinal
tract WM development assessed using DTI was reported to be
increased in acute and chronic stroke, yielding characteristic
impaired SMC movement patterns post-CST injury (Yeo and
Jang, 2010; Rüber et al., 2012). Cortical mapping with DTI in
stroke patients suggests that a loss of SMC is also associated
with increased overlap of joint representation in the sensorimotor
cortices (Yao et al., 2009). The reticulospinal tract originates in
the reticular formation in the midbrain and descends to act on
the motor neurons supplying the trunk and proximal limb flexors
and extensors (Mtui et al., 2016, p. 324–337). It is also thought
to modulate pain and influence muscle tone. Current research
suggests that infants rely on both the reticulospinal tract and
CST for movements, while adults rely primarily on the CST
(Forssberg, 1985; Yamaguchi and Goto, 2006). Loss of efferent
motor signals descending in the CST provides both excitatory
and inhibitory input to subcortical nuclei. Therefore, disruption
of these signals may reduce normal inhibition that contributes
to SMC. Further studies are needed to characterize development
and function of the rubrospinal and reticulospinal tracts, as well
as their response to CST injury in spastic CP and their potential
for plasticity for compensatory signal transduction and motor
function.
Impaired SMC has been assessed using the SCALE, an
observation-based measure for children with spastic CP (Fowler
et al., 2009). The SCALE has been proven to reliably and
systematically quantify the SMC of various joints involved in
children with CP. In addition, SCALE scores for children with
spastic CP correlate with the GMFCS (Fowler et al., 2009).
Further study will clarify neural correlates and the mechanism
underlying impaired SMC in spastic CP and guide more effective
treatment (Rose, 2009).
Neuromuscular Deficits in Dyskinetic CP
Dyskinetic CP is characterized by involuntary hyperkinetic or
repetitive dystonic limb movements that impair function (Sanger,
2006). More specifically, these movements are dystonic or
choreoathetotic in nature: involuntary, uncontrolled, recurring,
and occasionally stereotyped, in which the primitive reflex
patterns predominate and muscle tone fluctuates (Sankar and
Mundkur, 2005; Aravamuthan and Waugh, 2016). Dystonia
is a movement disorder in which involuntary sustained or
intermittent muscle contractions causes twisting and repetitive
movements, abnormal postures, or both (Sanger et al., 2003),
and choreoathetosis presents as a mix of chorea and athetosis.
Chorea is defined as an ongoing random-appearing sequence
of one or more discrete involuntary movements or movement
fragments, while athetosis is a slow, continuous, involuntary
writhing movement that prevents maintenance of a stable posture
(Sanger et al., 2010).
Sanger (2006) found that children with dyskinetic CP had
a significantly reduced signal-to-noise ratio compared with
TD children, indicating increased movement variability. This
finding is consistent with the hypothesis that inadequate removal
of noisy signals causes the movement disorder in dyskinetic
CP (Sanger, 2006). Most measures of dyskinetic CP have
focused solely on dystonia, ignoring choreoathetotic movements.
However, Monbaliu et al. (2016) created a scale to measure both
dystonia and choreoathetosis in dyskinetic CP, the “Dyskinetic
Impairment Scale.” The Dyskinetic Impairment Scale can assess
separate movement subscores and has been shown to have high
inter-rater reliability (Monbaliu et al., 2016). Further study of
neuromuscular deficits in dyskinetic CP will clarify their impact
on gait and guide more effective treatment.
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FIGURE 3 | The gait cycle showing muscles that are influenced by neuromuscular deficits and contribute to gait abnormalities in spastic CP, in
relation to phases of the gait cycle. IC, initial contact; OTO, opposite toe-off; OIC, opposite foot initial contact; TO, toe-off.
Neuromuscular Deficits in Ataxic CP
Ataxic CP is characterized by hypotonia, impaired limb
coordination, balance, and stability (Hughes and Newton, 1992;
Schnekenberg et al., 2015; Graham et al., 2016). Impaired balance
is well recognized in ataxic CP, however, the scope of other
neuromuscular deficits is not well studied. Postural balance
deficits assessed on center-of-pressure force plate measures were
identified in 8/23 children diagnosed with spastic diplegic CP
and gait abnormalities (Rose et al., 2002), suggesting mixed
forms of CP. However, the degree to which primary cerebellar
balance deficits versus biomechanical factors, such as foot contact
area and base of support impair balance in children with CP
is not well studied. The vermis of the cerebellum (Figure 1)
is thought to mediate posture and balance, and it is in this
region that the “extrapyramidal” vestibulospinal tract originates.
The vestibulospinal tract is comprised of the medial and lateral
vestibulospinal tracts. The lateral vestibulospinal tract innervates
paravertebral extensors and proximal limb extensors which
function to counteract the force of gravity and control posture
and balance (Mtui et al., 2016 p. 324–337). Recent studies of
treatment to improve balance in children with spastic and ataxic
CP are promising and include the application of cerebellar
transcranial direct current stimulation, in combination with
treadmill training (Lazzari et al., 2016).
INFLUENCE OF NEUROMUSCULAR
DEFICITS ON GAIT IN CEREBRAL
PALSY: TREATMENT IMPLICATIONS
Neuromuscular deficits of spastic, dyskinetic, and ataxic CP differ
and therefore influence gait in different ways. Neuromuscular
deficits include abnormal motor drive, muscle tone, motor
patterns, coordination, and sensorimotor impairments caused
by the original brain injury. Subsequent sensorimotor and
musculoskeletal changes also contribute to gait abnormalities in
children with CP.
The Influence of Neuromuscular Deficits
in Spastic CP
The neuromuscular deficits of spastic CP, including muscle
weakness, short muscle-tendon length, spasticity, and impaired
SMC influence gait in different but predictable ways and
contribute to common gait abnormalities such as plantar-flexed
gait, flexed-knee gait, or a stiff-knee gait. Plantar-flexed gait
includes both ‘drop-foot’ gait where weakness of the tibialis
anterior prevents adequate dorsiflexion in swing phase, as well
as equinus gait which arises from short and/or spastic plantar-
flexors and impacts both stance and swing phases of the gait
(Figure 3 and Table 2). In both cases there is typically forefoot
initial contact and disruption of the normal heel-toe progression
of gait. The plantarflexed position of the ankle causes an
early and ‘double bump’ plantarflexion moment that reduces
forward momentum. Additionally, the plantarflexed position
results in reduced foot contact area in stance that can impair
balance.
Flexed-knee gait can arise from short and spastic hip and knee
flexors, as well as from weak hip extensors and ankle plantar
flexors. Impaired SMC also contributes to flexed-knee gait and
results in diminished knee extension during the terminal-swing
phase of gait (Rha et al., 2016) (Figure 3 and Table 2). Flexed-
knee gait causes abnormal mechanical loads and muscle forces
across the hip and knee during stance. In young children, that
can result in bone deformities and a permanently flexed, rotated
gait later in life (Bell et al., 2002; Steele et al., 2012). In the
absence of full hip extension during early gait, the immature 30
degree femoral neck anteversion does not reduce to the normal 15
degrees of anteversion seen in TD children, resulting in internal
hip rotation in children with CP (Shefelbine and Carter, 2004).
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TABLE 2 | Neuromuscular deficits and their contributions to different gait abnormalities in spastic cerebral palsy, in terms of the muscles affected and
the timing during the gait cycle.
Neuromuscular deficit Muscle groups Gait cycle event Gait abnormality
Weakness Ankle Dorsiflexors: tibialis anterior IC, Swing Foot-slap, Drop-foot
Ankle Plantar flexors:
gastrocnemius, soleus
Single limb support Uncontrolled forward tibial rotation→
increased hip and knee flexion
Poor push-off mechanics→ reduced
knee flexion in swing
Knee Extensors: quadriceps
femoris
IC – Midstance Increased knee flexion
Hip Extensors: gluteus maximus,
hamstrings
IC – Midstance Increased hip flexion
Hip Flexors: iliopsoas Preswing Reduced peak knee flexion in swing
Hip Abductors: gluteus medius Single limb stance Contralateral pelvic drop and ipsilateral
trunk lean
Short Muscle-tendon Ankle: gastrocnemius, soleus Throughout gait cycle Increased ankle plantar flexion
posterior tibialis Throughout gait cycle Ankle equinovarus
Knee: hamstrings Stance, Terminal swing Increased knee flexion
Hip: iliopsoas Stance Increased hip flexion
adductors Throughout gait cycle Adducted, scissoring gait
gluteus medius Throughout gait cycle Internally rotated hip and foot
progression angle
Spasticity Ankle: gastrocnemius, soleus Stance, Terminal swing Increased ankle plantar flexion
posterior tibialis Throughout gait cycle Ankle equinovarus
Knee: hamstrings Single limb support Increased knee flexion
Hip: iliopsoas Pre-swing Reduced hip extension
rectus femoris Terminal stance,
Pre-Initial swing
Reduced hip extension,
Reduced knee flexion in swing
adductors Throughout gait cycle Adducted, scissoring gait
gluteus medius Throughout gait cycle Internally rotated hip and foot
progression angle
Impaired SMC Ankle: plantar flexor coupling with
knee extensors
IC, Terminal swing Forefoot IC
Ankle: plantar flexor coupling with
hip and knee extensors
Midstance Plantar flexed equinus gait→ knee
hyperextension in stance
Knee: knee flexor coupling with hip
flexors
Terminal swing Flexed knee at IC
Hip: slow transition from terminal
stance hip and knee extension to
hip and knee flexion in initial swing
Terminal stance – Midswing Reduced hip and knee flexion in early
swing→ reduced foot clearance
IC, initial contact.
Further compounding the problem, the internal rotation moment
arms of hip muscles, such as the anterior gluteus medius, increase
with flexed knee gait (Delp et al., 1999).
Stiff-knee gait arises from spastic knee extensors which
impair pre-swing mechanics that limit knee flexion in early
swing. In addition, hip flexor weakness impairs hip and
knee flexion in early swing, and impaired SMC slows the
transition from the stance phase hip and knee extension to
the swing phase hip and knee flexion. The neuromuscular
deficits contributing to stiff-knee gait primarily impact pre-
swing through mid-swing phases of gait in spastic CP (Figure 3
and Table 2). Here, we explore the influence of neuromuscular
deficits on gait in the three types of CP with a focus on
spastic CP.
The Influence of Weakness on Gait in Spastic CP:
Treatment Considerations
The impact of weakness in spastic CP most notably affects
ankle dorsiflexion in swing phase and hip and knee extension
in stance phase. Thus, weakness affects all phases of the gait
cycle (Figure 3 and Table 2). Weak ankle dorsiflexors result
in excessive ankle plantar flexion in swing and poor foot
clearance with compensatory motion such as hip circumduction
to clear the foot. Weak ankle dorsiflexors also cause excessive
plantar flexion at initial contact, disrupting the normal heel-toe
progression of gait. Weak plantar flexors fail to restrain tibial
forward rotation over the foot in mid stance, increasing hip
and knee flexion in stance. Furthermore, failure to stabilize the
ankle during heel rise reduces the normal ankle plantar-flexion
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moment in terminal stance and can decrease peak knee
flexion in swing. Weak hip and knee extensors contribute
to flexed hip and knee postures during the stance phase
of gait. Weak hip flexors can contribute to reduced peak
knee flexion in swing. Weak hip abductors cause contralateral
pelvic drop and increase ipsilateral trunk sway, shifting the
body’s center of mass closer to the hips’ axis of rotation
and thereby reducing the muscular demand on the hip
abductors.
Steele et al. (2012) found children walking in flexed hip
and knee gait had less passive skeletal support of body weight
and utilize substantially higher muscle forces to walk than
unimpaired individuals. Flexed hip and knee gait relied on
the same muscles as unimpaired gait to accelerate the mass
center upward, including the soleus, vasti, gastrocnemius, gluteus
medius, rectus femoris, and gluteus maximus. However, these
muscles were active throughout single-limb stance during
flexed-knee gait in order to resist gravity, in contrast to the
modulation of muscle forces seen during single-limb stance of
unimpaired gait (Steele et al., 2012). Further, muscle weakness
has been shown to have a negative effect on the Gait Profile
Score, a measure of overall gait function (Schweizer et al.,
2014).
Treatment with strength training targeting weak muscles
has been found to be effective at improving gait, although
further studies of targeted intensive strength training are
needed. Evidence is accumulating around strength training
as a means of improving mobility in CP without adverse
effects (Dodd et al., 2002; Scholtes et al., 2012). To elucidate
interventions that improve and maintain strength, i.e., force-
generating capacity, and endurance, Fowler et al. (2010)
studied 62 ambulatory children with spastic diplegic CP
who underwent 30 intensive stationary cycling episodes over
12 weeks. They saw improvements in locomotor endurance,
gross motor function, and some measures of strength in
the cycling group but not the control group (Fowler et al.,
2010). A review by Steele et al. (2012) found that individuals
without hamstring spasticity had greater improvement in
knee extension after strength training. In a study conducted
by Scholtes et al. (2012), there was an improvement in
muscle strength, but not mobility or spasticity, directly
after training among 51 children with spastic CP who
received 12 weeks of functional training; however, a detraining
effect was observed 6 weeks after training ended. Jung
et al. (2013) found that ankle plantarflexor strengthening
improved strength and spatiotemporal gait parameters of six
children with spastic CP. These subjects performed a heel
raise exercise, which included progressive resistance ankle
plantar flexor training for 6 weeks. In patients for whom
weakness is a major contributor to gait deficits, strength
training (as measured by force-generating capacity) in the
extensor muscle groups may improve walking function and
alignment, though further studies are needed to confirm
kinematic and functional improvements (Damiano et al.,
2010). Repetitive functional electrical stimulation to induce
muscle strengthening has shown evidence of use-dependent
muscle growth in children with CP with foot drop, though
lasting improvements in voluntary ankle control have not
been demonstrated (Damiano et al., 2013). More research is
needed to develop the most effective treatment strategies for
lasting improvements in strength that translate to improved gait
function.
The Influence of Short Muscle-Tendon Units on Gait
in Spastic CP: Treatment Considerations
Short muscle-tendon units of the hip and knee flexors and
ankle plantar-flexors, particularly the bi-articular muscles,
contribute to joint contracture and abnormal joint mechanics,
and represent a primary cause of gait abnormalities in spastic
CP (Figure 3 and Table 2). Short plantar flexor muscle-
tendon unit contributes to excessive ankle plantarflexion in
stance and swing, leading to toe-walking or ‘equinus’ gait
which limits foot clearance in swing. Equinus may co-exist
with ankle dorsiflexor weakness, further impairing normal ankle
dorsiflexion in swing phase. Limited foot clearance in swing
causes compensatory movements such as hip circumduction
in swing to clear the foot. A shortened posterior tibialis can
contribute to equinovarus gait, which includes plantarflexion,
inversion, and adduction of the foot. In cases of moderate to
severe spastic CP where there is both distal and proximal limb
involvement, flexed-knee gait is a common debilitating gait
abnormality that creates abnormal mechanics across the hip,
knee, and ankle that can result in bone deformity and increased
fatigue while walking. Short semitendinosus contributes to two-
thirds of all cases of flexed-knee gait (Arnold et al., 2006)
at both initial contact and during the single limb support
phase of the gait cycle. Musculoskeletal models of hamstring
length and lengthening velocity just prior to initial contact
quantify the contribution of short hamstrings to flexed knee
gait (Arnold et al., 2006) and guide treatment decisions.
Rha et al. (2016) found that a short medial gastrocnemius
correlated with increased knee flexion at initial contact, whereas
a short semitendinosus correlated with increased knee flexion
at both initial contact and single limb support. In more severe
cases, proximal involvement of hip flexors, adductors, and
internal rotators contribute to flexed, adducted, and internally
rotated gait. Recently, Kalsi et al. (2016) found an increased
lengthening of the medial gastrocnemius during stance phase
of gait in children with unilateral spastic CP compared to TD
subjects, suggesting greater muscle excursion demands during
gait.
Treatments for shortened muscle-tendon units in spastic
CP include tendon lengthening and serial casting, however,
both contribute to muscle weakness. In contrast, treatments
that promote strength and increase muscle fiber diameter
may also increase muscle length given the pennate angle of
muscle fascicles (Shortland et al., 2001; Gough and Shortland,
2012). Treatment with muscle growth factors has not been
well studied to date, however, it has potential to increase
muscle size and length and warrants investigation as a treatment
for CP. Work by Smith et al. (2009) and Barber et al.
(2016) point to the importance of characterizing the nature
of shortened muscle-tendon units and investigating growth
factors as a potential therapy. While the impact of shortened
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muscle on gait has been fairly well studied, an optimal
solution that preserves strength has not been developed. Further
research can elucidate the links between WM brain injury,
loss of normal neuromuscular activation to affected muscles,
impaired musculoskeletal growth, short muscle-tendon unit,
and the resulting gait abnormalities may lead to more effective
treatments.
The Influence of Spasticity on Gait in Spastic CP:
Treatment Considerations
Spasticity contributes to gait abnormalities by further
compounding abnormal joint postures and by restraining
normal rapid flexion or extension during gait. Spasticity
contributes to excessive ankle plantarflexion, knee flexion,
and hip flexion, adduction, and/or rotation (Figure 3 and
Table 2). Plantarflexor spasticity increases the equinus deformity
of the ankle contributing to toe-walking and forefoot only
contact in stance and poor foot clearance in swing. Spasticity
of the posterior tibialis increases the equinovarus deformity of
the foot, which includes ankle plantarflexion, inversion, and
adduction. Hamstrings spasticity can limit knee extension in
terminal swing and lead to increased knee flexion at initial
contact. Indeed, Steele et al. (2012) found that hamstring
spasticity was associated with an undesirable increase in
knee flexion during walking. Stiff-knee gait can result from
increased spasticity and passive resistance to stretch in the
rectus femoris, thereby restricting the normal rapid knee flexion
in early swing and limiting peak knee flexion. Hip adductor
spasticity can lead to an adducted, scissoring gait, contributing
to tripping. Spasticity of the hip internal or external hip rotators
will contribute to an internally or externally rotated hip,
respectively.
Treatments for spasticity include BoNT-A injections, oral or
intrathecal baclofen, and dorsal rhizotomy. However, treatments
that promote strength may also be effective. A study conducted
by Williams et al. (2013) found that simultaneous use of BoNT-
A and strength training was successful in spasticity reduction,
improving strength, and achieving functional goals, over and
above treatment with BoNT-A alone in 15 children (aged 5–
12 years) with spastic diplegic CP. Further research is needed
to assess the efficacy of treatments that promote strength,
such as intensive strength training and functional electrical
stimulation, for reducing spasticity and improving overall gait
function.
The Influence of Impaired Selective Motor Control on
Gait in Spastic CP: Treatment Considerations
Impaired SMC results in obligatory muscle co-activation of flexor
or extensor muscle synergies during gait. For example, at least
three gait events are impacted by impaired SMC (Figure 3 and
Table 2). Ankle plantarflexion in terminal swing may increase
when the knee is extending as part of an extensor synergy, leading
to a forefoot initial contact. Increased ankle plantarflexion may
also occur in stance when the knee is normally extended as
part of an extensor synergy, leading to equinus gait and knee
hyperextension. Knee extension in terminal swing may be limited
when the hip is normally flexed as part of a flexor synergy,
leading to a flexed-knee posture at initial contact. Rha et al.
(2016) showed that while a short semitendinosus correlated
with increased knee flexion at both initial contact and single
limb support, impaired SMC assessed using the SCALE proved
to be a stronger correlate of knee flexion at initial contact
than semitendinosus length. In addition, a slow transition from
hip and knee extension in terminal stance to hip and knee
flexion in initial swing leads reduced foot clearance in swing
due to reduced hip and knee flexion. Chruscikowski et al.
(2017) studied 194 patients with bilateral CP and found a
significant, negative correlation between SMC measured using
SCALE and gait impairment, as measured by Gait Profile
Score, suggesting that impaired SMC negatively affects gait
function.
Recently, Shuman et al. (2016) examined EMG patterns
of muscle activation during gait in CP and found increased
patterns of muscle synergies. They developed an EMG analysis to
quantify synergy patterns during gait and found that prolonged
antigravity muscle activation is necessary to prevent collapse
in flexed-knee gait. However, prolonged and simultaneous
antigravity muscle activation may be a compensatory symptom,
separate from impaired SMC and therefore requires further
delineation.
Treatments utilizing intensive exercise patterns outside of
synergy patterns, such as knee extension combined with
ankle dorsiflexion, may prove beneficial and warrant further
investigation. Research is needed to determine the efficacy of
intensive exercise on improving SMC using exercise patterns that
combine flexion and extension of adjacent joints. Further work
is needed to determine if improvements in SMC translates to
improved gait patterns.
The Influence of Neuromuscular Deficits
on Gait in Dyskinetic CP
Dyskinetic CP is characterized by involuntary hyperkinetic or
repetitive dystonic limb movements that impair motor function
(Sanger, 2006). Primitive reflexes are more prominent and
persist for a longer time in dyskinetic CP and may interfere
with gait (Sankar and Mundkur, 2005). The influence of
neuromuscular deficits in dyskinetic CP is not well studied.
However, the increased movement variability and involuntary
muscle contractions in children with dyskinetic CP (Sanger, 2006;
Sanger et al., 2010) undoubtedly impact gait. Further, children
with dystonia are at risk of developing fixed musculoskeletal
deformities, which progress faster with worsening GMFCS level
and among children with both dystonia and spasticity (Lumsden
et al., 2016). Determining whether dyskinetic movements are
random and variable or involve a small number of specific
abnormal motor patterns (Sanger, 2006) will clarify the influence
on gait and guide more effective treatment.
Deep brain stimulation to the globus pallidus internus may
be an effective treatment option for children with dyskinetic
CP (Review: Koy et al., 2013). It has been shown that response
to pallidal deep brain stimulation in the treatment of dystonia
yields better outcomes if administered earlier in life (<7 years
of age) (Lumsden et al., 2013), highlighting a need for early
intervention.
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The Influence of Neuromuscular Deficits
on Gait in Ataxic CP
Ataxic CP is characterized by impaired limb coordination,
balance, and stability (Hughes and Newton, 1992; Schnekenberg
et al., 2015; Graham et al., 2016). These neuromuscular deficits
impose instability and result in a compensatory wider base
of support and elevated, outreaching arm postures to improve
balance during gait. In addition, a more circuitous or less
direct gait path may be observed. Little work has been done to
specifically characterize the neuromuscular deficits in ataxic CP
and their influence on gait. Better characterization of the deficits
can help develop more effective treatment methods.
Neural Correlates of Gait Abnormalities
in CP
To date, few studies have examined the neural correlates of
motor deficits and gait abnormalities. Staudt et al. (2003)
found correlations (r = 0.8; p < 0.01) between lower limb
motor dysfunction assessed with the Movement ABC and
extent of contralateral PVL, as assessed on semi-coronal
reconstructions from 3D-MRI in 13 adolescents with CP. In
addition, Rademaker et al. (2004) found an inverse association
between motor function assessed on Movement ABC scores
and corpus callosum area assessed on MRI in 204 preterm
children with VLBW. The association existed in frontal, middle,
and posterior corpus callosum areas but increased in the
direction of the posterior part. Lee et al. (2011) found a
strong relationship between motor dysfunction assessed with
GMFCS and fractional anisotropy values assessed on DTI within
the bilateral CST and posterior body of the corpus callosum
(p < 0.03); Cortical volume of the pre- and post-central gyri,
and the paracentral lobule was negatively associated with GMFCS
levels (p< 0.005).
Meyns et al. (2016b) found that the severity of gait
abnormality assessed using the Gait Profile Score correlated to
total corpus callosum (r = −0.441; p < 0.040) and subpart
1 (r = −0.437; p < 0.042) volumes in children with CP
(Witelson, 1989). Furthermore, Rose et al. (2007) found evidence
to support early prognosis of gait abnormalities in VLBW
preterm children. They found that neonatal WM microstructure
of the posterior limbs of the internal capsule assessed with DTI
fractional anisotropy correlated to severity of gait abnormalities
at 4 years of age, measured using 3D kinematics (r = 0.89,
p < 0.0) and to GMFCS (r = 0.65, p < 0.04). In a
separate cohort of VLBW preterm children, gait velocity at 18–
22 months of age correlated (r = −0.374, p < 0.007) with
near term brain microstructure in the genu of the corpus
callosum assessed on DTI mean diffusivity (Rose and McGill,
1998).
CONCLUSION
Emerging evidence suggest that important links exist between
neurologic injury, neuromuscular deficits, and specific gait
abnormalities in CP. A better understanding of these
relationships can elucidate underlying mechanisms of gait
impairments and lead to more strategic treatments. Here, we
have reviewed the nature of brain injuries in CP, the associated
neuromuscular deficits, and the subsequent gait abnormalities
on both a microscopic and functional level.
Our understanding of brain abnormalities in CP have
been informed by rapidly evolving neuroimaging techniques.
However, inconsistent methodology and reporting of data
limit interpretation. These discrepancies have been identified
as “(1) inappropriate assignment of etiology to morphologic
findings, (2) inconsistent descriptions of radiologic findings,
(3) uncertain relationship of pathologic findings to brain insult
timing estimates, and (4) study designs that are not based on
generalizable samples” (Korzeniewski et al., 2008). In addition,
consistent, standardized language across studies would help
compare findings in context of the existing body of knowledge.
Neuroimaging findings are rarely reported with anatomical
descriptions sufficient for direct comparison between studies.
For example, the localization of atrophy of GM or WM, the
location of cavities, and the nature of anomalies found on
imaging are not specified in a consistent manner. However,
the National Institute of Neurological Disorders and Stroke
(NINDS), in conjunction with the American Academy for
Cerebral Palsy and Developmental Medicine (AACPDM) have
recently developed a set of Common Data Elements for use in CP
research, including neuroimaging diagnostics, which promises
to standardize clinical language and improve data collection
consistency for future research on CP (Odenkirchen et al.,
2016).
The criteria for estimating the time of injury are also
not well described; thus, exactly how prenatal and perinatal
insults are differentiated is unclear, and there is a need to
develop accurate, standardized techniques. Automated analysis
of MRI is an exciting new field that can facilitate precise
identification of brain abnormalities and improve consistency
in the interpretation of MRI scans. Automated brain lesion
segmentation using the Least Absolute Shrinkage and Selection
Operator (LASSO) on both WM and GM from T1-weighted
MRI sequences was recently validated against manual expert
classifications of lesions (Pagnozzi et al., 2016). The prognostic
ability of MRI to determine mild motor impairment and
exactly which motor functions will be compromised is still
limited. Thus, further work on developing a quantitative
relationship between lesion burden and functional outcome
will help increase the utility of structural MRI in predicting
individual prognoses and planning targeted therapeutic
interventions.
Precision in identifying microstructural brain abnormalities
on DTI will also advance our understanding of brain
abnormalities in CP. Current DTI techniques are limited
by spatial resolution, intravoxel averaging of anisotropy by
adjacent tracts, partial volume effects, and image artifacts. DTI
imaging of the reticulospinal and rubrospinal tracts will improve
our understanding of the contribution of these tracts to gait
abnormalities in children with CP. Developments to the diffusion
tensor model, which uses optimized acquisition schemes,
such as high angular resolution diffusion imaging (HARDI)
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(Tuch et al., 2002) and higher-order modeling of diffusion
anisotropy, will improve the resolution of crossing fibers within
each voxel. With better resolution, more accurate estimations of
tract injury or plasticity within corticomotor networks can be
made (Rose et al., 2011). Multi-modal imaging such as functional
neuroimaging (functional MRI or magnetoencephalography)
guided DTI holds promise for correlating structure-function
relations in children with CP (Reid et al., 2016). Improved
techniques to precisely quantify neuromuscular deficits in CP
are also needed to clarify these important structure-function
relations.
By discussing the neurologic correlates of gait abnormalities
within this context, we hope to encourage the reader to recognize
specific mechanisms of gait abnormalities in CP and discover
targeted treatment opportunities that can substantially improve
functional outcomes for children with CP.
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